Cargando…

Managing medicines at the end of life: a position paper for health policy and practice

PURPOSE: The impact of population ageing is significant, multifaceted and characterised by frailty and multi-morbidity. The COVID-19 pandemic has accelerated care pathways and policies promoting self-management and home-based care. One under-researched area is how patients and family caregivers mana...

Descripción completa

Detalles Bibliográficos
Autores principales: Latif, Asam, Faull, Christina, Waring, Justin, Wilson, Eleanor, Anderson, Claire, Avery, Anthony, Pollock, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Emerald Publishing Limited 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136861/
https://www.ncbi.nlm.nih.gov/pubmed/34841822
http://dx.doi.org/10.1108/JHOM-11-2020-0440
_version_ 1784714275591290880
author Latif, Asam
Faull, Christina
Waring, Justin
Wilson, Eleanor
Anderson, Claire
Avery, Anthony
Pollock, Kristian
author_facet Latif, Asam
Faull, Christina
Waring, Justin
Wilson, Eleanor
Anderson, Claire
Avery, Anthony
Pollock, Kristian
author_sort Latif, Asam
collection PubMed
description PURPOSE: The impact of population ageing is significant, multifaceted and characterised by frailty and multi-morbidity. The COVID-19 pandemic has accelerated care pathways and policies promoting self-management and home-based care. One under-researched area is how patients and family caregivers manage the complexity of end-of-life therapeutic medicine regimens. In this position paper the authors bring attention to the significant strain that patients and family caregivers experience when navigating and negotiating this aspect of palliative and end-of-life care. DESIGN/METHODOLOGY/APPROACH: Focussing on self-care and organisation of medicines in the United Kingdom (UK) context, the paper examines, builds on and extends the debate by considering the underlying policy assumptions and unintended consequences for individual patients and family care givers as they assume greater palliative and end-of-life roles and responsibilities. FINDINGS: Policy makers and healthcare professionals often lack awareness of the significant burden and emotional work associated with managing and administering often potent high-risk medicines (i.e. opioids) in the domiciliary setting. The recent “revolution” in professional roles associated with the COVID-19 pandemic, including remote consultations and expanding community-based care, means there are opportunities for commissioners to consider offering greater support. The prospect of enhancing the community pharmacist's medicine optimisation role to further support the wider multi-disciplinary team is considered. ORIGINALITY/VALUE: The paper takes a person-focused perspective and adopts a holistic view of medicine management. The authors argue for urgent review, reform and investment to enable and support terminally ill patients and family caregivers to more effectively manage medicines in the domiciliary setting. There are clear implications for pharmacists and these are discussed in the context of public awareness, inter-professional collaboration, organisational drivers, funding and regulation and remote care delivery.
format Online
Article
Text
id pubmed-9136861
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Emerald Publishing Limited
record_format MEDLINE/PubMed
spelling pubmed-91368612022-06-13 Managing medicines at the end of life: a position paper for health policy and practice Latif, Asam Faull, Christina Waring, Justin Wilson, Eleanor Anderson, Claire Avery, Anthony Pollock, Kristian J Health Organ Manag Research Paper PURPOSE: The impact of population ageing is significant, multifaceted and characterised by frailty and multi-morbidity. The COVID-19 pandemic has accelerated care pathways and policies promoting self-management and home-based care. One under-researched area is how patients and family caregivers manage the complexity of end-of-life therapeutic medicine regimens. In this position paper the authors bring attention to the significant strain that patients and family caregivers experience when navigating and negotiating this aspect of palliative and end-of-life care. DESIGN/METHODOLOGY/APPROACH: Focussing on self-care and organisation of medicines in the United Kingdom (UK) context, the paper examines, builds on and extends the debate by considering the underlying policy assumptions and unintended consequences for individual patients and family care givers as they assume greater palliative and end-of-life roles and responsibilities. FINDINGS: Policy makers and healthcare professionals often lack awareness of the significant burden and emotional work associated with managing and administering often potent high-risk medicines (i.e. opioids) in the domiciliary setting. The recent “revolution” in professional roles associated with the COVID-19 pandemic, including remote consultations and expanding community-based care, means there are opportunities for commissioners to consider offering greater support. The prospect of enhancing the community pharmacist's medicine optimisation role to further support the wider multi-disciplinary team is considered. ORIGINALITY/VALUE: The paper takes a person-focused perspective and adopts a holistic view of medicine management. The authors argue for urgent review, reform and investment to enable and support terminally ill patients and family caregivers to more effectively manage medicines in the domiciliary setting. There are clear implications for pharmacists and these are discussed in the context of public awareness, inter-professional collaboration, organisational drivers, funding and regulation and remote care delivery. Emerald Publishing Limited 2021-11-18 2021 /pmc/articles/PMC9136861/ /pubmed/34841822 http://dx.doi.org/10.1108/JHOM-11-2020-0440 Text en © Asam Latif, Christina Faull, Justin Waring, Eleanor Wilson, Claire Anderson, Anthony Avery and Kristian Pollock https://creativecommons.org/licenses/by/4.0/Published by Emerald Publishing Limited. This article is published under the Creative Commons Attribution (CC BY 4.0) licence. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this licence may be seen at https://creativecommons.org/licenses/by/4.0/
spellingShingle Research Paper
Latif, Asam
Faull, Christina
Waring, Justin
Wilson, Eleanor
Anderson, Claire
Avery, Anthony
Pollock, Kristian
Managing medicines at the end of life: a position paper for health policy and practice
title Managing medicines at the end of life: a position paper for health policy and practice
title_full Managing medicines at the end of life: a position paper for health policy and practice
title_fullStr Managing medicines at the end of life: a position paper for health policy and practice
title_full_unstemmed Managing medicines at the end of life: a position paper for health policy and practice
title_short Managing medicines at the end of life: a position paper for health policy and practice
title_sort managing medicines at the end of life: a position paper for health policy and practice
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136861/
https://www.ncbi.nlm.nih.gov/pubmed/34841822
http://dx.doi.org/10.1108/JHOM-11-2020-0440
work_keys_str_mv AT latifasam managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice
AT faullchristina managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice
AT waringjustin managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice
AT wilsoneleanor managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice
AT andersonclaire managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice
AT averyanthony managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice
AT pollockkristian managingmedicinesattheendoflifeapositionpaperforhealthpolicyandpractice